-2.75 (-0.17%) Sun Pharmaceutical Industries has received one observation from US Food and Drug Administration (USFDA) for its Baska manufacturing facility in the state of Gujarat. The USFDA had conducted a pre-approval inspection (PAI) of Baska facility from January 28 to February 5, 2019.
Sun Pharmaceutical Industries is the world’s fourth largest specialty generic pharmaceutical company and India’s top pharmaceutical company.